AI Use in Breast Cancer Screening Cuts Later Diagnoses by 12%, Study Finds

A Swedish trial found that artificial intelligence reduced later breast cancer diagnoses by 12% and improved early detection.
The study followed 100,000 women in national mammography screening programmes.
Researchers compared AI-supported screening with standard double readings by radiologists.
AI flagged high-risk cases for closer review and reduced workload on specialists.
The results, published in The Lancet, showed more cancers detected at screening stage.
The AI group also recorded fewer aggressive cancer subtypes.
Lead author Kristina Lång of Lund University said AI could support radiologists, not replace them.
Experts welcomed the findings but urged caution before wider rollout.